No, paracetamol use in pregnancy is not linked to autism, confirms study

Debunking Donald Trump's recent claims, a new BMJ study finds no convincing evidence that taking paracetamol during pregnancy raises the risk of autism or ADHD in children

pregnancy
Scientists urge pregnant women not to fear using paracetamol when medically needed. (Photo: AdobeStock)
Barkha Mathur New Delhi
4 min read Last Updated : Nov 10 2025 | 4:01 PM IST
There’s reassuring news for expectant mothers: taking paracetamol during pregnancy is not linked to autism or ADHD in children, according to a major scientific review.
 
The findings, published this week in the British Medical Journal (BMJ), counter US President Donald Trump’s September claim that prenatal use of painkillers such as acetaminophen were to blame for rising autism cases. The study re-examined existing evidence, and what it found should put many worried minds at ease.
 
The researchers behind the study, titled Maternal paracetamol (acetaminophen) use during pregnancy and risk of autism spectrum disorder and attention deficit/hyperactivity disorder in offspring: umbrella review of systematic reviews, said existing evidence does not support any connection between prenatal paracetamol use and these neurodevelopmental conditions.

What did the BMJ study examine?

The BMJ umbrella review is one of the most comprehensive analyses on this subject to date. It pooled findings from nine systematic reviews covering 40 separate studies that explored whether taking paracetamol during pregnancy could increase the risk of autism or ADHD in children.
 
The researchers, led by Prof Shakila Thangaratinam and her team from the University of Liverpool, found that while some earlier studies hinted at a possible link, most of those studies were of low or very low quality. When the better-quality data were examined, especially studies comparing siblings (to control for family genetics and environment), the supposed link disappeared entirely.

Why did some earlier studies suggest a link?

According to the researchers, many previous studies that associated paracetamol use with autism or ADHD failed to account for key confounding factors that can blur cause and effect.
 
For example, families with a history of neurodevelopmental conditions like autism or ADHD are more likely to have children diagnosed with these conditions regardless of what medications the mother took during pregnancy. When researchers controlled for such genetic and environmental factors, the small associations reported earlier vanished.

Is paracetamol safe to take while pregnant?

According to the researchers, doctors worldwide, and global health authorities such as the World Health Organization and European Medicines Agency, yes, it is safe when used correctly. Paracetamol remains the recommended treatment for fever and pain in pregnancy, endorsed by health agencies and clinicians.
 
“Avoiding paracetamol when it’s medically needed, for instance, during high fever or pain, could harm both the mother and baby, as untreated fever in pregnancy increases risks of complications. Acetaminophen is one of the safest options available to pregnant patients to treat pain and fever, which can be harmful when left untreated,” said Dr S Sachidananda Kamath, paediatrician and neonatal specialist, and former president of the Indian Academy of Pediatrics (IAP).

Why was the BMJ review released now?

According to media reports, the review’s release was accelerated after US President Donald Trump claimed in September 2025 that the use of painkillers like Tylenol (acetaminophen) during pregnancy was behind rising autism rates. His comments triggered anxiety among expectant mothers and confusion among clinicians, prompting scientists to clarify the evidence and reaffirm paracetamol’s safety. 

Since you're already here

…and clearly interested in your health, take a moment to explore our varied range of stories on wellness, medical research, and public health insights.

For more health updates, follow #HealthWithBS 
This content is for informational purposes only and is not a substitute for professional medical advice.
 
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Health with BSBS Web ReportsHealth Ministryhealth newsparacetamolpregnancyautismADHDChild health in India

First Published: Nov 10 2025 | 3:32 PM IST

Next Story